Interrupting RNA activity can improve survival chances in pancreatic cancer patients ANI | Updated: Apr 24, 2021 17:15 IST
Nagoya [Japan], April 24 (ANI): During a recent study, researchers uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. A patient s response to therapy and their overall survival chance can be increased by targeting an RNA to interrupt its activity.
The study led by Nagoya University researchers and colleagues in Japan was published in the journal Cancer Research. Pancreatic cancer is one of the most aggressive human malignancies, with an overall med ian survival that is less than five months, says cancer biologist Yutaka Kondo of Nagoya University Graduate School of Medicine. This poor prognosis is partially due to a lack of potent therapeutic strategies against pancreatic cancer, so more effective treatments are urgently needed.